This site is intended for healthcare professionals
Journals
  • Home
  • /
  • Journals
  • /
  • Eosinophilic esophagitis
  • /
  • Eosinophilic Esophagitis: Incidence, Diagnosis, Ma...
Journal

Eosinophilic Esophagitis: Incidence, Diagnosis, Management, and Future Directions

Read time: 1 mins
Published:30th Nov 2021
Author: Fernandez-Becker NQ.
Availability: Pay for access, or by subscription
Ref.:Gastroenterol Clin North Am. 2021 Dec;50(4):825-841.
DOI:10.1016/j.gtc.2021.08.001
Eosinophilic Esophagitis: Incidence, Diagnosis, Management, and Future Directions


Eosinophilic esophagitis (EoE) is an antigen-mediated esophageal disease defined by the presence of esophageal eosinophilia and symptoms of esophageal dysfunction. The pathophysiology involves an allergen-driven Th2 T cell response that triggers infiltration of eosinophils into the esophagus leading to inflammation, remodeling, and fibrosis. This results in disruption of esophageal function and accompanying symptoms - most notably dysphagia. Effective therapies target inflammation or fibrostenotic complications and include proton pump inhibitors, swallowed topical steroids, dietary exclusion, and dilation. Clinical trials testing promising biologic therapies are ongoing.


Read abstract on library site    Access full article